Scilex Holding Company, a Sorrento Company, Announces That
SP-103 receives Fast Track Designation, which makes it eligible for some or all of the following: More frequent meetings or written communication with the...
Source: globenewswire.com
Page 5 - Text View News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Text View. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Text View Today - Breaking & Trending Today
Children with Chronic Graft Versus Host Disease (cGVHD) May Now Be Prescribed IMBRUVICA® (ibrutinib)
The U.S. Food and Drug Administration approved the use of IMBRUVICA for the treatment of pediatric patients one year and older with cGVHD after failure of one...
Source: prnewswire.com
Guerbet receives EMA acceptance of Elucirem as the Brand Name for Gadopiclenol
VILLEPINTE, France, June 13, 2022 /PRNewswire/ -- Guerbet (EuronextParis: GBT) (ISIN: FR0000032526), a global leader in medical imaging, announces today that Elucirem, the proposed Guerbet brand
Source: finanznachrichten.de
Scilex, a Sorrento Company, Announces Initiation of a Phase
Dosing of the first subject in a Phase 2, randomized, double-blind, placebo-controlled, parallel group, multicenter study to evaluate the safety and...
Source: globenewswire.com
Scilex, a Sorrento Company, Announces Pivotal Phase 3 SP-102 (SEMDEXA) Data Presentation At The American Society Of Interventional Pain (ASIPP) 2022 Annual Meeting
06.05.2022 - SP-102 (SEMDEXATM) is the first non-opioid novel injectable corticosteroid gel formulation product in development for the treatment of lumbar radicular pain, and it contains no preservatives, surfactants, solvents, or particulates.The study met its ...
Source: wallstreet-online.de